» Articles » PMID: 32464691

The C-terminal Domains of the NMDA Receptor: How Intrinsically Disordered Tails Affect Signalling, Plasticity and Disease

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 2020 May 29
PMID 32464691
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

NMDA receptors are part of the ionotropic glutamate receptor family, and are crucial for neurotransmission and memory. At the cellular level, the effects of activating these receptors include long-term potentiation (LTP) or depression (LTD). The NMDA receptor is a stringently gated cation channel permeable to Ca , and it shares the molecular architecture of a tetrameric ligand-gated ion channel with the other family members. Its subunits, however, have uniquely long cytoplasmic C-terminal domains (CTDs). While the molecular gymnastics of the extracellular domains have been described in exquisite detail, much less is known about the structure and function of these CTDs. The CTDs vary dramatically in length and sequence between receptor subunits, but they all have a composition characteristic of intrinsically disordered proteins. The CTDs affect channel properties, trafficking and downstream signalling output from the receptor, and these functions are regulated by alternative splicing, protein-protein interactions, and post-translational modifications such as phosphorylation and palmitoylation. Here, we review the roles of the CTDs in synaptic plasticity with a focus on biochemical mechanisms. In total, the CTDs play a multifaceted role as a modifier of channel function, a regulator of cellular location and abundance, and signalling scaffold control the downstream signalling output.

Citing Articles

Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology.

Korinek M, Candelas Serra M, Abdel Rahman F, Dobrovolski M, Kuchtiak V, Abramova V Physiol Res. 2024; 73(Suppl 1):S413-S434.

PMID: 38836461 PMC: 11412357. DOI: 10.33549/physiolres.935346.


N-Methyl-D-Aspartate (NMDA) Receptor Antagonists and their Pharmacological Implication: A Medicinal Chemistry-oriented Perspective Outline.

Rana V, Ghosh S, Bhatt A, Bisht D, Joshi G, Purohit P Curr Med Chem. 2024; 31(29):4725-4744.

PMID: 38638036 DOI: 10.2174/0109298673288031240405061759.


Limb-Clasping Response in NMDA Receptor Palmitoylation-Deficient Mice.

Suzuki N, Oota-Ishigaki A, Kaizuka T, Itoh M, Yamazaki M, Natsume R Mol Neurobiol. 2024; 61(11):9125-9135.

PMID: 38592586 PMC: 11496324. DOI: 10.1007/s12035-024-04166-9.


Disease-associated nonsense and frame-shift variants resulting in the truncation of the GluN2A or GluN2B C-terminal domain decrease NMDAR surface expression and reduce potentiating effects of neurosteroids.

Kysilov B, Kuchtiak V, Hrcka Krausova B, Balik A, Korinek M, Fili K Cell Mol Life Sci. 2024; 81(1):36.

PMID: 38214768 PMC: 10786987. DOI: 10.1007/s00018-023-05062-6.


Trans-synaptic molecular context of NMDA receptor nanodomains.

Anderson M, Dharmasri P, Damenti M, Metzbower S, Laghaei R, Blanpied T bioRxiv. 2024; .

PMID: 38187545 PMC: 10769418. DOI: 10.1101/2023.12.22.573055.